• PyloVaxx AG

    AI
    active
    Check credit rating Timeline
    Check credit ratingCredit rating
    Register number: CH-310.3.003.091-1
    Sector: Research and development

    Age of the company

    5 years

    Turnover in CHF

    PremiumPremium

    Capital in CHF

    100'000

    Employees

    PremiumPremium

    Active brands

    0

    Reports for PyloVaxx AG

    *displayed reports are examples
    preview

    Credit rating information

    Evaluation of credit rating with traffic light as risk indicator and other helpful data about the company.
    Find out more
    preview

    Economic information

    Comprehensive information about the economic situation of a company.
    Find out more
    preview

    Payment behaviour

    Assessment of the payment behaviour based on past invoices.
    Find out more
    preview

    Payment collection information

    Overview of current and past debt enforcement proceedings.
    Find out more
    preview

    Company dossier as PDF

    Contact information, changes in the company, turnover and employee figures, management, ownership, shareholding structure and other company data.
    Retrieve company dossier

    About PyloVaxx AG

    • PyloVaxx AG is a Company limited by shares (AG) with its legal headquarters in Appenzell Meistersrüte. PyloVaxx AG belongs to the industry «Research and development» and is currently active.
    • There is one active person registered in the management.
    • The company has last modified its commercial register entry on 07.10.2024. All previous commercial register entries are available under «Notifications».
    • The company's UID is CHE-311.943.255.
    • The address is identical with 5 other active companies. These include: Baran Biotech AG, RaCorDiax Biotech AG, Spectral Solution AG.

    Management (1)

    newest board members

    Walter Miedl

    newest authorized signatories

    Walter Miedl

    Source: SOGC

    Commercial register information

    Source: SOGC

    Sector

    Research and development

    Purpose (Original language)

    Die Gesellschaft bezweckt die Forschung an therapeutischen Mitteln und Verfahren gegen Infektionen und neoplastische Stammzellen, Entwicklung und Verwertung von Patenten, Vornahme von Provisionsgeschäften und Entwicklung an Verbesserungen des Immunsystems. Die Gesellschaft kann Zweigniederlassungen und Tochtergesellschaften im In- und Ausland errichten und sich an anderen Unternehmen im In- und Ausland beteiligen. Die Gesellschaft kann Grundstücke und Liegenschaften erwerben, verwalten und veräussern. Die Gesellschaft kann alle kommerziellen, finanziellen und anderen Tätigkeiten ausüben, welche mit dem Zweck der Gesellschaft im Zusammenhang stehen.

    Customise the company purpose with just a few clicks.

    Other company names

    Source: SOGC

    Past and translated company names

    • StemStatin AG
    Would you like to update the company name? Click here.

    Branches (0)

    Ownership structure

    No information on the ownership structure is known to us.

    Holdings

    No information on holdings is known to us.

    Newest SOGC notifications: PyloVaxx AG

    The latest updates from the Swiss Official Gazette of Commerce (SOGC) are available in the original language of the source commercial register office only. View all notifications

    SOGC 241007/2024 - 07.10.2024
    Categories: Change of company address

    Publication number: HR02-1006147258, Commercial Registry Office Appenzell I. Rh., (310)

    PyloVaxx AG, in Appenzell, CHE-311.943.255, Aktiengesellschaft (SHAB Nr. 189 vom 30.09.2024, Publ. 1006141199).

    Domizil neu:
    Gadenstatt 19, 9050 Appenzell Meistersrüte.

    SOGC 240930/2024 - 30.09.2024
    Categories: Change in management

    Publication number: HR02-1006141199, Commercial Registry Office Appenzell I. Rh., (310)

    PyloVaxx AG, in Appenzell, CHE-311.943.255, Aktiengesellschaft (SHAB Nr. 129 vom 05.07.2024, Publ. 1006077199).

    Eingetragene Personen neu oder mutierend:
    Miedl, Walter, deutscher Staatsangehöriger, in Appenzell, Mitglied des Verwaltungsrates, mit Einzelunterschrift [bisher: in Kloten].

    SOGC 240705/2024 - 05.07.2024
    Categories: Change of company address, Change in management

    Publication number: HR02-1006077199, Commercial Registry Office Appenzell I. Rh., (310)

    PyloVaxx AG, in Schwende-Rüte, CHE-311.943.255, Aktiengesellschaft (SHAB Nr. 89 vom 09.05.2022, Publ. 1005468849).

    Statutenänderung:
    28.06.2024.

    Sitz neu:
    Appenzell.

    Domizil neu:
    Gaiserstrasse 10, 9050 Appenzell.

    Ausgeschiedene Personen und erloschene Unterschriften:
    Nisple, Emil, von Appenzell, in Appenzell, Mitglied, mit Einzelunterschrift.

    Eingetragene Personen neu oder mutierend:
    Miedl, Walter, deutscher Staatsangehöriger, in Kloten, Mitglied des Verwaltungsrates, mit Einzelunterschrift.

    Hit list

    Here you will find a link from the management to a hit list of persons with the same name who are registered in the commercial register.

    Title
    Confirm